Malika Sahni
Bharat Express News Network
TCS to continue Investing in R&D, Technology, Offices Spaces Amid Volatilities
The largest IT services provider in India, TCS, will keep investing at the same rate in R&D and office space. It will also invest in technology infrastructure as it navigates near-term volatility
Tata Motors To Increase Car Prices For The Second Time In 2023; Know Why
Tata Motors has made the decision to raise the prices of its passenger cars
Blinkit Delivery Partners Continue Strike In Delhi-NCR
The Zomato-owned quick-commerce platform's service, Blinkit, has been impacted by a protest organised by delivery partners in the cities of Delhi, Noida, Gurugram, and Faridabad over changes to the compensation structure.
Commercial Calls To Get Different Number Series
The Telecom Regulatory Authority of India's (TRAI) plan to give businesses a new set of phone numbers for service-related commercial calls that are not for promotional reasons has received approval from the Department of Telecommunications (DoT).
ArcelorMittal Contracts with Siemens Gamesa to Build 166 MW Wind Project.
Siemens Gamesa has inked a supply deal with the Indian division of ArcelorMittal for a project of 166 MW in Andhra Pradesh to provide 46 SG 3.6-145 wind turbines
Inflation Plunges Below Tolerance Band Of 6%
Retail inflation as measured by the Consumer Price Index (CPI) decreased to 5.66%, the lowest in 15 months.
TCS Q4 Results: Profit Rises 14.8% to Rs 11,392 Crore
India’s top IT company, Tata Consultancy Services profit soared 14.7 per cent to Rs 11,392 crore net profit in the quarter that ended March 2023 as compared to Rs 9,926 in the prior year.
Former Chairman Of Mahindra & Mahindra Group Keshub Mahindra Passes Away
The former chairman of the Mahindra & Mahindra Group of Companies and one of India’s oldest billionaires, Keshub Mahindra, passed away on Wednesday in Mumbai at the age of 99.
IMF chief Praises India’s Economy As It Continues To Perform Well
Indian economy will continue to do well and hold its place as one of the fastest-growing economies in the world.
Cipla Signs Licence Agreement with Novartis AG; Will Manufacture Type-2 Diabetes Medicine From 2026
From January 2026, Cipla Limited will be manufacturing Galvus and Galvus combination brands that are used in the treatment of type 2 diabetes
